A positive spin with EvolvBelieve this is excellent news from our competitior : they just confirmed that the fundamentals of the market are strong. So, good for them if they pick new clients/schools with their product, there will be more than enough for Xtract to pick up. After all, One is still not approved for selling and it is our Expedite killer.... A bit surprised that they can sell that product, it validates the demand in the market for a superior prodcut.
Lets face it, for the moment, Xtract can grow but is limited by its capital. Pretty sure that current shareholders would be pissed off by a raise.
In the meantime, I like the emphasis on England that should bring in new revenus.
GLTA,